AG
KRTX

Algert Global’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Algert Global’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,176
Closed -$4.49M – 1320
2023
Q4 		$4.49M Sell
14,176
-4,250
-23% -$826K 0.18% 168
2023
Q3 		$3.12M Buy
18,426
+11,730
+175% +$2.21M 0.15% 227
2023
Q2 		$1.45M Sell
6,696
-10,030
-60% -$2.15M 0.06% 513
2023
Q1 		$3.04M Buy
16,726
+7,871
+89% +$1.51M 0.14% 213
2022
Q4 		$1.74M Buy
8,855
+900
+11% +$193K 0.1% 339
2022
Q3 		$1.79M Buy
7,955
+5,814
+272% +$1.18M 0.11% 307
2022
Q2 		$271K Hold
2,141
– – 0.02% 944
2022
Q1 		$271K Buy
+2,141
New +$241K 0.02% 972

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Algert Global's KRTX Position: Q1 2024 in Review

Algert Global sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 14,176 shares — an estimated $4.49M sold.

Algert Global first reported a position in KRTX in Q1 2022 and held it in 8 quarters. The position peaked at $4.49M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Algert Global reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Algert Global sold 14,176 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $4.49M.
  • Algert Global first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Algert Global's Karuna Therapeutics, Inc. Common Stock position peaked at $4.49M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Algert Global's 13F filing for Q1 2024, filed 15 May 2024.